OUR PARTNERS

ASTRAZENECA

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company focused on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and Biopharma, including Cardiovascular, Renal and Metabolism, and Respiratory and Immunology. Headquartered in Cambridge, UK, AstraZeneca operates in more than 125 countries and its innovative medicines are used by millions of patients worldwide. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.

César Velasco

Innovation Director
Dr. César Velasco, M.D., Ph.D., is a specialist in preventive medicine and public health with over 15 years of international experience. As Head of Strategy and Digital Innovation at AstraZeneca Spain, he connects healthcare ecosystems with AstraZeneca’s R&D to tackle health challenges. His career highlights include roles at the European Centre for Disease Prevention and Control, WHO during the Ebola outbreak, and leadership positions at Vall d’Hebron Hospital, where he introduced transformative care models. He has also held executive roles in Catalonia’s Health Department and led innovation at Novartis. César holds a medical degree, a Ph.D. cum laude from the University of Barcelona, and advanced degrees from ESADE, Pompeu Fabra, and Harvard Business School. With expertise in digital health, AI, and Health Technology Assessment, he advises WHO on Ebola vaccination and has published widely on vaccines, public health, and HIV.

SUBSCRIBE TO OUR NEWSLETTER

Join our mailing list to receive the latest project news

Newsletter register

Privacy

Your subscription

By subscribing to this list, you accept to receive information about events, news and/or newsletters about the PRECISEU. The personal data collected will only be used to send you the newsletter(s) you chose to opt in to above. You can change your mind at any time by clicking the "unsubscribe" link in the footer of any email you receive from us. We will treat your information with respect.